ANTI-CANCER DRUGS[ta] - Search Results

Year	Number of Results
1990	26
1991	67
1992	102
1993	104
1994	90
1995	133
1996	142
1997	150
1998	121
1999	126
2000	119
2001	128
2002	137
2003	124
2004	132
2005	146
2006	153
2007	151
2008	130
2009	132
2010	123
2011	135
2012	135
2013	126
2014	140
2015	130
2016	133
2017	136
2018	123
2019	144
2020	147
2021	142
2022	333
2023	185
2024	84

1

Assessment in vitro of interactions between anti-cancer drugs and noncancer drugs commonly used by cancer patients.

Andersson CR, Ye J, Blom K, Fryknäs M, Larsson R, Nygren P. Andersson CR, et al. Anticancer Drugs. 2023 Jan 1;34(1):92-102. doi: 10.1097/CAD.0000000000001344. Epub 2022 Aug 31. Anticancer Drugs. 2023. PMID: 36066384 Free PMC article.

2

Anti-tumoral effect of beta-blockers on prostate and bladder cancer cells via mitogen-activated protein kinase pathways.

Özler S, Pazarci P. Özler S, et al. Anticancer Drugs. 2022 Apr 1;33(4):384-388. doi: 10.1097/CAD.0000000000001271. Anticancer Drugs. 2022. PMID: 35266887

3

A systematic review and meta-analysis on overall survival, failure-free survival and safety outcomes in patients with metastatic hormone-sensitive prostate cancer treated with new anti-androgens.

Ramos-Esquivel A, Garita-Rojas E, Masis-Marroquín A. Ramos-Esquivel A, et al. Anticancer Drugs. 2023 Mar 1;34(3):405-412. doi: 10.1097/CAD.0000000000001419. Epub 2022 Nov 15. Anticancer Drugs. 2023. PMID: 36730553

4

Anti-cancer effectiveness of a novel ceramide analog on chemo-sensitive and chemo-resistant breast cancers.

Ponnapakkam T, Saulsberry T, Hill-Odom M, Beamon T, Hooks R, Goyal N, Shaik S, Anbalagan M, Foroozesh M. Ponnapakkam T, et al. Anticancer Drugs. 2024 Jan 1;35(1):12-21. doi: 10.1097/CAD.0000000000001536. Epub 2023 Aug 15. Anticancer Drugs. 2024. PMID: 37578744

5

Research progress of CXCR3 inhibitors.

Yuan Z. Yuan Z. Anticancer Drugs. 2024 Jan 1;35(1):36-45. doi: 10.1097/CAD.0000000000001543. Epub 2023 Sep 11. Anticancer Drugs. 2024. PMID: 37694856 Review.

6

ADAR1 affects gastric cancer cell metastasis and reverses cisplatin resistance through AZIN1.

Wang H, Yang L, Liu R, He H, Zhang M, Xu Y. Wang H, et al. Anticancer Drugs. 2023 Nov 1;34(10):1132-1145. doi: 10.1097/CAD.0000000000001516. Epub 2023 Apr 28. Anticancer Drugs. 2023. PMID: 37104086 Free PMC article.

7

Mechanisms of GZ17-6.02 resistance.

Booth L, West C, Von Hoff D, Dent P. Booth L, et al. Anticancer Drugs. 2022 Jun 1;33(5):415-423. doi: 10.1097/CAD.0000000000001203. Anticancer Drugs. 2022. PMID: 35276694

8

Risk-tailored treatment of splenic marginal zone lymphoma.

Castelli R, Balzarotti M, Salvi E, Simona Rossi R, Lambertenghi Deliliers G, Bergamaschini L, Gidaro A. Castelli R, et al. Anticancer Drugs. 2022 Jan 1;33(1):e36-e42. doi: 10.1097/CAD.0000000000001165. Anticancer Drugs. 2022. PMID: 34407041 Review.

9

A novel ribociclib derivative WXJ-103 exerts anti-breast cancer effect through CDK4/6.

Ji J, Zhang Z, He X, Pan G, Li G, Lv J, Xu Y, Xie M, Feng J, Wang W, Liu B, Ma J, Wang X. Ji J, et al. Anticancer Drugs. 2023 Aug 1;34(7):803-815. doi: 10.1097/CAD.0000000000001475. Epub 2022 Dec 19. Anticancer Drugs. 2023. PMID: 36729405 Free PMC article.

10

STK25: a viable therapeutic target for cancer treatments?

Chen KQ, Lei GL, Ke BY, Chen L, Wang ZB, Wang SZ. Chen KQ, et al. Anticancer Drugs. 2023 Oct 1;34(9):995-1001. doi: 10.1097/CAD.0000000000001490. Epub 2023 Dec 23. Anticancer Drugs. 2023. PMID: 36728989 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

4,500 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

4,500 results

Results by year